Leading Sites

Category

Kansas City MO Clinical Investigator Overseeing Two Vaccines Including Moderna’s mRNA-1273

A Kansas City, Missouri-based clinical investigational site is working overtime during the COVID-19 pandemic, which is quite the opposite for many research sites that saw their work with sponsors crawl to a halt during the slow downs.  Alliance for Multispecialty...

Bangladesh’s International Centre for Diarrheal Disease Research Launches Phase II Ivermectin Clinical Trial

That Bangladesh could become a future hub of clinical research is palpable based on a number of unfolding trends.  TrialSite News discussed the nation of nearly 165 million—the 8th most populated in the world—with a dynamic and rapidly growing economy, innovative and...

COVID-19 Vaccine Race Moves to Halifax as Canadian Volunteers Eager to Participate in CanSino Biologics Study of Ad5-nCoV

Just hours after an announcement by Justin Trudeau, Prime Minister of Canada, that the nation’s first COVID-19 vaccine clinical trial would commence soon, Canadians sent waves of unsolicited emails offering to volunteer to the Canadian Center for Vaccinology (CCfV) at...

AMR Lexington in Central Kentucky Enrolls Participants for INO-4800 COVID-19 Vaccine Clinical Trial

Deborah Dyer, RN, BSN, founded a clinical investigational site in Kentucky known as Central Kentucky Research Associates (CKRA) along with the late Jacqueline Smith, RN, BSN. CKRA was Kentucky’s first independent  clinical research facilities and one of the few owned...

Cincinnati Children’s Investigator Idea May Lead to Answer to COVID-19 Deadly Cytokine Storm: Ruxolitinib

Cincinnati Children’s researchers initially developed a transgenic mouse to model HLH (hemophagocytic lymphohistiocytosis), a deadly childhood immune disease but as it now turns out this effort may end up saving lives during the COVID-19 pandemic. Cincinnati...

UC San Diego’s ACTRI Driving Results, $55m of New Funding & an Exciting Future for 8th Largest U.S. City

The Altman Clinical and Translational Research Institute (ACTRI) at University of California San Diego received a five-year, $54.7 million Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Science (NCATS), part of the...

New Jersey-based Hackensack Meridian Health a Force for COVID-19 Research Treating 1,000 Clinical Trial Patients

Hackensack Meridian Health, a network of New Jersey-based health providers, reached a major milestone in serving as a COVID-19 clinical investigational center—treating 1,000 patients with the latest investigative treatments during the pandemic. From antiviral drugs to...

Prominent NYC Trust Awards $1.4m to Monash & Doherty Institute to Advance Ivermectin Research Targeting COVID-19

The growing interest in ivermectin as a possible treatment for patients infected with SARS-CoV-2, the virus behind the COVID-19 pandemic, was triggered by a laboratory experiment in a cell culture undertaken by Australian-based scientists at Monash University and the...

Atlantic Health System Transitions to ‘New Normal’ for Next Two Years: Will Clinical Trials go Partially Remote?

Recently, Atlantic Health System President and CEO Brian Gragnolati discussed the meaning of the “new normal” as the provider moves forward out of the worst of the pandemic. An important regional health system, the New Jersey-based, not-for-profit health system has a...

HHMI-backed Johns Hopkins Hosted Team Investigates Use of Alpha Blockers (Prazosin) to Combat a Deadly COVID-19 Condition: Cytokine Storm

Although considered eccentric toward the end, Howard Hughes was incredibly rich and put that capital to work in many interesting and important ways, including what has become one of the largest private funding organizations for biological medical research in the...

UCLA Jonsson Center PI Leads Study to Suppress Male Hormone in Attempt to Reduce COVID-19 Severity

University of Los Angeles, California (UCLA) researchers are pursuing COVID-19 via a commonly used method to treat men with prostate cancer in an effort to help drive improved clinical outcomes for individuals afflicted with SARS-CoV-2, the virus behind COVID-19....

Northern Kentucky’s St. Elizabeth Hospital the First Site to Dose COVID-19 Patients with PUL-042

St. Elizabeth Hospital in Edgewood, Kentucky, was selected as the first clinical investigational site for a Phase II clinical trial studying a new drug to treat COVID-19 called PUL-042, an inhalation solution under investigation to help COVID-19 from progressing in...

Canada’s Horizon Health Network the First Health Authority in Canada to Receive Accreditation for its HRPP by HRA Canada

The Horizon Health Network became the first health authority in Canada to receive national accreditation of its human research protection program (HRPP) via the Human Research Accreditation Canada (HRA Canada). The HRPP is the system through which all research studies...

KKR-backed Major Indian Health Care Provider Conducting Ivermectin Study Investigating the Benefits in Combating COVID-19

Max Healthcare, a modern hospital chain in India, was founded to offer integrated, high-end “unparalleled” health care services. With 14 hospitals, the group recently merged with KKR-backed Radiant Life Care and has entered the research war against...

How to Convert Doctors to Principal Investigators: Mayo Clinic’s National COVID-19 Convalescent Plasma Expanded Access Study

Back in early April, TrialSite News received huge interest in a national COVID-19 Convalescent Plasma study titled “Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19” led by Michael Joyner of the Mayo Clinic. Upon our promotion of this...

Taiwan’s Chang Gung University Teams with Australian Researchers to Study Potential of Ivermectin Targeting COVID-19

Australia’s Monash University, along with the University of Melbourne and Taiwan’s Chang Gung University, signed a collaboration and nondisclosure agreement centering on the development of new drugs for potential use against viruses, including SARS-CoV-2—the virus...

Spanish Research Center Launches Ivermectin Clinical Trial Targeting Mild COVID-19 Patients

Clinical Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a center supported by "la Caixa” Foundation, have launched a clinical trial to investigate the efficacy of ivermectin against COVID-19. The study team will combine ivermectin...

Pin It on Pinterest